Join to View Full Profile
500 Foothill DrResearch 151Salt Lake City, UT 84148
Phone+1 801-584-1271
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Angela Huttner, MD is an internist in Salt Lake City, Utah.
Clinical Trials
- Immune Durability After VSV-EBOV Vaccination Start of enrollment: 2016 Nov 01
- Antibiotic Durations for Gram-negative Bacteremia Start of enrollment: 2017 Apr 27
- The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring Start of enrollment: 2019 Jan 14
Publications & Presentations
PubMed
- Seven vs Fourteen Days of Antibiotics for Gram-Negative Bloodstream Infection: A Systematic Review and Noninferiority Meta-Analysis.Todd C Lee, Connor J Prosty, Michael Fralick, Angela Huttner, Emily G McDonald
JAMA Network Open. 2025-03-03 - 1 citationsWhich trial do we need? Three-day course of antibiotics for acute pyelonephritis in immunocompetent women.Stijn Bex, Antonio Leidi, Christophe Marti, Vanina Meyssonnier, Angela Huttner
Clinical Microbiology and Infection. 2024-03-01 - 7 citationsAntibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.Angela Huttner, Selidji Todagbe Agnandji, Olivier Engler, Jay W Hooper, Steve Kwilas
Clinical Microbiology and Infection. 2023-12-01
Press Mentions
- Impact of Restricting Procalcitonin Measurements in a Swiss Tertiary-Care Hospital on Antibiotic Use, Clinical Outcomes, and Costs: An Interrupted Time-Series AnalysisDecember 2nd, 2020
Fewer Antibiotics to Better Fight Bacterial InfectionsJune 5th, 2020
The Lancet Infectious Diseases: New Investigational Antibiotic Effective Against Drug-Resistant Bacteria in Phase 2 TrialOctober 30th, 2018- Join now to see all
